Toggle navigation
Home
Search
Services
Blog
Contact
About
Therapy for Chemotherapy Alopecia with Pthrp Analogs
Holick, Michael F.
Cutanogen, Inc., Sudbury, MA, United States
Search 146 grants from Michael Holick
Search grants from Cutanogen, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Publications
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
The Role of PPARa in Cardiac Dysfunction in Sepsis
Deep Sequencing of CNR1 Gene Network in Substance Dependence
p27 &apoptosis resistance in gastric cancer
Asta Z 7557 (Mafosfamide): Mechanism of Action
Studies on Vitamin A
Recently added grants:
Biomarkers to Improve Targeting of Breast Cancer Prevention in Women with Atypical Hyperplasia
Identification of a central player in neoplastic transformation of intestinal stem cells:protocadherin 8
Study of Break-induced Replication in Mammalian Cells
AMPLIFIed muscle mass in older cancer survivors enrolled in a diet-exercise program
Selective vulnerability of discrete neural circuits in the striatum to HIV-opiate comorbidity
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Small Business Technology Transfer (STTR) Grants - Phase I (R41)
Project #
1R41CA071119-01
Application #
2114842
Study Section
Special Emphasis Panel (ZRG7-SSS-Z (15))
Project Start
1996-08-01
Project End
1997-11-30
Budget Start
1996-08-01
Budget End
1997-11-30
Support Year
1
Fiscal Year
1996
Total Cost
Indirect Cost
Institution
Name
Cutanogen, Inc.
Department
Type
DUNS #
City
Sudbury
State
MA
Country
United States
Zip Code
01776
Publications
Peters, E M; Foitzik, K; Paus, R et al.
(2001)
A new strategy for modulating chemotherapy-induced alopecia, using PTH/PTHrP receptor agonist and antagonist.
J Invest Dermatol 117:173-8
Comments
Be the first to comment on Michael Holick's grant